{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:27:20Z","timestamp":1794832040908,"version":"4.9.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/ftd.0000000000000242","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T08:48:36Z","timestamp":1441356516000},"page":"87-97","source":"Crossref","is-referenced-by-count":26,"title":["Determination of Common Antipsychotics in Quantisal-Collected Oral Fluid by UHPLC-MS\/MS"],"prefix":"10.1097","volume":"38","author":[{"given":"Lisbeth","family":"Patteet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof E.","family":"Maudens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Morrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Sabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Dom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Neels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":". Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2004.01.027","article-title":"A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.","volume":"55","author":"Mishara","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jad.2010.11.009","article-title":"Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute maniaa systematic review and meta-analysis.","volume":"134","author":"Tarr","year":"2011","journal-title":"J Affect Disord"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/JCP.0b013e3181f15849","article-title":". Treatment options for bipolar depression: a systematic review of randomized, controlled trials.","volume":"30","author":"Vieta","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":". AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/FTD.0b013e3182708ec5.","article-title":". Therapeutic drug monitoring of common antipsychotics.","volume":"34","author":"Patteet","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/FTD.0b013e318283eaf2","article-title":". Plasma, oral fluid, and whole-blood distribution of antipsychotics and metabolites in clinical samples.","volume":"35","author":"Fisher","year":"2013","journal-title":"Ther Drug Monit"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.4088\/JCP.v67n1008","article-title":". Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review.","volume":"67","author":"Valenstein","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FTD.0b013e3181ae46ea","article-title":". Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.","volume":"31","author":"Wille","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/jat\/30.8.614","article-title":"Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device.","volume":"30","author":"Quintela","year":"2006","journal-title":"J Anal Toxicol"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chroma.2014.06.096","article-title":"Rapid quantitative chiral amphetamines liquid chromatography-tandem mass spectrometry: method in plasma and oral fluid with a cost-effective chiral derivatizing reagent.","volume":"1358","author":"Newmeyer","year":"2014","journal-title":"J Chromatogr A"},{"key":"R12-12-20210129","first-page":"147","article-title":"Drug testing in oral fluid.","volume":"27","author":"Drummer","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1749-6632.1993.tb18347.x","article-title":"Factors influencing the salivaplasma ratio of drugs.","volume":"694","author":"Haeckel","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00003088-199936060-00006","article-title":"Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants.","volume":"36","author":"Liu","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FTD.0b013e31827c11e7","article-title":"Therapeutic drug monitoring of antiepileptic drugs by use of saliva.","volume":"35","author":"Patsalos","year":"2013","journal-title":"Ther Drug Monit"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.forsciint.2013.02.010","article-title":". LC-MSMS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.","volume":"229","author":"Fisher","year":"2013","journal-title":"Forensic Sci Int"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clinbiochem.2011.03.135","article-title":". Correlation of haloperidol levels between saliva and plasma of acutely ill schizophrenic patients.","volume":"44","author":"Jain","year":"2011","journal-title":"Clin Biochem"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.chroma.2003.10.138","article-title":". Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry.","volume":"1026","author":"Flarakos","year":"2004","journal-title":"J Chromatogr A"},{"key":"R19-12-20210129","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.talanta.2010.02.067","article-title":". Analysis of risperidone and its metabolite in plasma and saliva by LC with coulometric detection and a novel MEPS procedure.","volume":"81","author":"Saracino","year":"2010","journal-title":"Talanta"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2013.11.024","article-title":". High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry.","volume":"429","author":"Patteet","year":"2014","journal-title":"Clin Chim Acta"},{"key":"R21-12-20210129","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/dta.1660","article-title":". Evaluation of Delta(9) -tetrahydrocannabinol detection using DrugWipe5S screening and oral fluid quantification after Quantisal collection for roadside drug detection via a controlled study with chronic cannabis users.","volume":"7","author":"Wille","year":"2015","journal-title":"Drug Test Anal"},{"key":"R22-12-20210129","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/dta.1784","article-title":". Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration.","volume":"7","author":"Newmeyer","year":"2015","journal-title":"Drug Test Anal"},{"key":"R25-12-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00769-011-0775-0","article-title":". Practical aspects concerning validation and quality control for forensic and clinical bioanalytical quantitative methods.","volume":"16","author":"Wille","year":"2011","journal-title":"Accredit Qual Assur"},{"key":"R26-12-20210129","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MSMS.","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem"},{"key":"R27-12-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/FTD.0b013e318278dbe4","article-title":". Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MSMS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector.","volume":"35","author":"Wille","year":"2013","journal-title":"Ther Drug Monit"},{"key":"R28-12-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/dta.1532","article-title":". Comparison of drug concentrations between whole blood and oral fluid.","volume":"6","author":"Langel","year":"2014","journal-title":"Drug Test Anal"},{"key":"R30-12-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jat\/32.6.393","article-title":". Drug testing in oral fluid-evaluation of sample collection devices.","volume":"32","author":"Langel","year":"2008","journal-title":"J Anal Toxicol"},{"key":"R31-12-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jat\/34.2.64","article-title":". Antidepressant drugs in oral fluid using liquid chromatography-tandem mass spectrometry.","volume":"34","author":"Coulter","year":"2010","journal-title":"J Anal Toxicol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T22:46:41Z","timestamp":1718059601000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201602000-00012"}},"subtitle":["Method Validation and Applicability for Therapeutic Drug Monitoring"],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000242","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}